• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Allosterically Potentiated 7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.变构增强的 7 型烟碱型乙酰胆碱受体:降低钙通透性和钙内流的电流非依赖性调控。
Mol Pharmacol. 2020 Dec;98(6):695-709. doi: 10.1124/molpharm.120.000012. Epub 2020 Oct 5.
2
Allosteric Agonism of 7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site.7 型烟碱型乙酰胆碱受体的变构激动作用:变构部位以外的受体调节。
Mol Pharmacol. 2019 Jun;95(6):606-614. doi: 10.1124/mol.119.115758. Epub 2019 Apr 3.
3
Macroscopic and Microscopic Activation of 7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.7 型烟碱型乙酰胆碱受体的宏观和微观激活:结构不相关的变构激动剂-正变构调节剂(ago-PAMs)B-973B 和 GAT107。
Mol Pharmacol. 2019 Jan;95(1):43-61. doi: 10.1124/mol.118.113340. Epub 2018 Oct 22.
4
Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.持续激活 α7 型烟碱型乙酰胆碱受体与不同脱敏状态的稳定诱导有关。
Br J Pharmacol. 2018 Jun;175(11):1838-1854. doi: 10.1111/bph.13851. Epub 2017 Jun 8.
5
Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.α7烟碱型乙酰胆碱受体变构激活的关键分子决定因素:直接变构激活与正变构调节的分离
J Biol Chem. 2016 Mar 4;291(10):5049-67. doi: 10.1074/jbc.M115.692392. Epub 2016 Jan 7.
6
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.GAT107 的活性是由跨越亚基界面的芳香族氨基酸调节的,GAT107 是一种变构激活剂和α7 烟碱型乙酰胆碱受体 (nAChR) 的正变构调节剂。
J Biol Chem. 2014 Feb 14;289(7):4515-31. doi: 10.1074/jbc.M113.524603. Epub 2013 Dec 20.
7
Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.结构多样的化学类型揭示了α7烟碱型乙酰胆碱受体阳性变构调节的不同特征。
Mol Pharmacol. 2007 Sep;72(3):715-24. doi: 10.1124/mol.107.035410. Epub 2007 Jun 12.
8
A series of α7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties.一系列具有紧密化学相似性但具有不同药理学性质的α7 烟碱型乙酰胆碱受体变构调节剂。
Mol Pharmacol. 2012 May;81(5):710-8. doi: 10.1124/mol.111.076026. Epub 2012 Feb 10.
9
Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance.α7 型烟碱型乙酰胆碱受体正构和变构激动剂的激活:对单通道动力学和电导率的影响。
Mol Pharmacol. 2012 Nov;82(5):910-7. doi: 10.1124/mol.112.080259. Epub 2012 Aug 8.
10
Differential Activation and Desensitization States Promoted by Noncanonical 7 Nicotinic Acetylcholine Receptor Agonists.非经典 7 型烟碱型乙酰胆碱受体激动剂诱导的激活和脱敏状态的差异。
J Pharmacol Exp Ther. 2022 Nov;383(2):157-171. doi: 10.1124/jpet.122.001354. Epub 2022 Sep 2.

引用本文的文献

1
Dissecting current rectification through asymmetric nanopores.通过不对称纳米孔剖析电流整流现象。
Biophys J. 2025 Feb 18;124(4):597-603. doi: 10.1016/j.bpj.2024.11.3318. Epub 2024 Nov 29.
2
The Role of Alpha-7 Nicotinic Acetylcholine Receptors in Pain: Potential Therapeutic Implications.α7烟碱型乙酰胆碱受体在疼痛中的作用:潜在的治疗意义。
Curr Neuropharmacol. 2025;23(2):129-144. doi: 10.2174/1570159X22666240528161117.
3
Symmetrical Bispyridinium Compounds Act as Open Channel Blockers of Cation-Selective Ion Channels.对称双吡啶化合物作为阳离子选择性离子通道的开放通道阻滞剂。
ACS Pharmacol Transl Sci. 2024 Feb 15;7(3):771-786. doi: 10.1021/acsptsci.3c00308. eCollection 2024 Mar 8.
4
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.基于 5-(奎宁环-3-基甲基)-1,2,4-噁二唑骨架的新型 Alpha9 nAChR 配体。
ACS Chem Neurosci. 2024 Feb 21;15(4):827-843. doi: 10.1021/acschemneuro.3c00720. Epub 2024 Feb 9.
5
Dose-dependent effects of GAT107, a novel allosteric agonist-positive allosteric modulator (ago-PAM) for the α7 nicotinic cholinergic receptor: a BOLD phMRI and connectivity study on awake rats.新型α7烟碱型胆碱能受体变构激动剂-正变构调节剂(ago-PAM)GAT107的剂量依赖性效应:对清醒大鼠的BOLD功能磁共振成像及连接性研究
Front Neurosci. 2023 Jun 23;17:1196786. doi: 10.3389/fnins.2023.1196786. eCollection 2023.
6
Differential Activation and Desensitization States Promoted by Noncanonical 7 Nicotinic Acetylcholine Receptor Agonists.非经典 7 型烟碱型乙酰胆碱受体激动剂诱导的激活和脱敏状态的差异。
J Pharmacol Exp Ther. 2022 Nov;383(2):157-171. doi: 10.1124/jpet.122.001354. Epub 2022 Sep 2.
7
Homomeric and Heteromeric α7 Nicotinic Acetylcholine Receptors in Health and Some Central Nervous System Diseases.健康及某些中枢神经系统疾病中的同聚体和异聚体α7烟碱型乙酰胆碱受体
Membranes (Basel). 2021 Aug 29;11(9):664. doi: 10.3390/membranes11090664.
8
Therapeutic Targeting of 7 Nicotinic Acetylcholine Receptors.治疗性靶向 7 型烟碱型乙酰胆碱受体
Pharmacol Rev. 2021 Jul;73(3):1118-1149. doi: 10.1124/pharmrev.120.000097.
9
Stable desensitization of α nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site.NS6740 通过与正位激动剂结合位点中的 S36 相互作用稳定失敏α烟碱型乙酰胆碱受体。
Eur J Pharmacol. 2021 Aug 15;905:174179. doi: 10.1016/j.ejphar.2021.174179. Epub 2021 May 15.

本文引用的文献

1
Methamphetamine regulation of activity and topology of ventral midbrain networks.甲基苯丙胺对腹侧中脑网络活动和拓扑结构的调节。
PLoS One. 2019 Sep 19;14(9):e0222957. doi: 10.1371/journal.pone.0222957. eCollection 2019.
2
Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant Subunits Acquire Sensitivity to 7-Selective Positive Allosteric Modulators.具有突变亚基的异源型神经元烟碱型乙酰胆碱受体获得对 7 型选择性正变构调节剂的敏感性。
J Pharmacol Exp Ther. 2019 Aug;370(2):252-268. doi: 10.1124/jpet.119.259499. Epub 2019 Jun 7.
3
B-973, a Novel α7 nAChR Ago-PAM: Racemic and Asymmetric Synthesis, Electrophysiological Studies, and Evaluation.B-973,一种新型α7烟碱乙酰胆碱受体激动剂-正向变构调节剂:外消旋体和不对称合成、电生理研究及评估
ACS Med Chem Lett. 2018 Oct 11;9(11):1144-1148. doi: 10.1021/acsmedchemlett.8b00407. eCollection 2018 Nov 8.
4
Macroscopic and Microscopic Activation of 7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.7 型烟碱型乙酰胆碱受体的宏观和微观激活:结构不相关的变构激动剂-正变构调节剂(ago-PAMs)B-973B 和 GAT107。
Mol Pharmacol. 2019 Jan;95(1):43-61. doi: 10.1124/mol.118.113340. Epub 2018 Oct 22.
5
Ionotropic and Metabotropic Mechanisms of Allosteric Modulation of 7 Nicotinic Receptor Intracellular Calcium.7 型烟碱型乙酰胆碱受体变构调节的离子型和代谢型机制:细胞内钙离子。
Mol Pharmacol. 2018 Jun;93(6):601-611. doi: 10.1124/mol.117.111401. Epub 2018 Mar 27.
6
Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.通过突变和修订后的结构模型揭示烟碱型乙酰胆碱受体正变构调节剂的多样性。
Mol Pharmacol. 2018 Feb;93(2):128-140. doi: 10.1124/mol.117.110551. Epub 2017 Dec 1.
7
Anti-inflammatory Silent Agonists.抗炎性沉默激动剂
ACS Med Chem Lett. 2017 Sep 26;8(10):989-991. doi: 10.1021/acsmedchemlett.7b00368. eCollection 2017 Oct 12.
8
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.神经烟碱型乙酰胆碱受体作为疼痛和炎症靶点的新见解:聚焦于α7 nAChR。
Curr Neuropharmacol. 2018;16(4):415-425. doi: 10.2174/1570159X15666170818102108.
9
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.α7烟碱型乙酰胆碱受体与核过氧化物酶体增殖物激活受体-α之间的相互作用代表了小鼠体内一种新的抗伤害感受信号通路。
Exp Neurol. 2017 Sep;295:194-201. doi: 10.1016/j.expneurol.2017.06.014. Epub 2017 Jun 9.
10
NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain.NACHO 介导整个大脑中的烟碱型乙酰胆碱受体功能。
Cell Rep. 2017 Apr 25;19(4):688-696. doi: 10.1016/j.celrep.2017.04.008.

变构增强的 7 型烟碱型乙酰胆碱受体:降低钙通透性和钙内流的电流非依赖性调控。

Allosterically Potentiated 7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.

机构信息

Departments of Neuroscience (D.R.M., H.K.) and Pharmacology and Therapeutics (C.S., R.L.P.), University of Florida, Gainesville, Florida; and Department of Pharmaceutical Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts (S.G., L.N.C., G.T.).

Departments of Neuroscience (D.R.M., H.K.) and Pharmacology and Therapeutics (C.S., R.L.P.), University of Florida, Gainesville, Florida; and Department of Pharmaceutical Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts (S.G., L.N.C., G.T.)

出版信息

Mol Pharmacol. 2020 Dec;98(6):695-709. doi: 10.1124/molpharm.120.000012. Epub 2020 Oct 5.

DOI:10.1124/molpharm.120.000012
PMID:33020143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7662531/
Abstract

The currents of 7 nicotinic acetylcholine receptors activated by acetylcholine (ACh) are brief. The channel has high permeability to calcium relative to monovalent cations and shows inward rectification. It has been previously noted that in the presence of positive allosteric modulators (PAMs), currents through the channels of 7 receptors differ from normal 7 currents both in sensitivity to specific channel blockers and their current-voltage (I-V) relationships, no longer showing inward rectification. Linear I-V functions are often associated with channels lacking calcium permeability, so we measured the I-V functions of 7 receptors activated by ACh when PAMs were bound to the allosteric binding site in the transmembrane domain. Currents were recorded in chloride-free Ringer's solution with low or high concentrations of extracellular calcium to determine the magnitude of the reversal potential shift in the two conditions as well as the I-V relationships. ACh-evoked currents potentiated by the allosteric agonist-PAMs (ago-PAMs) (3aR,4S,9bS)-4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (GAT107) and 3-(3,4-difluorophenyl)--(1-(6-(4-(pyridin-2-yl)piperazin-1-yl)pyrazin-2-yl)ethyl)propenamide (B-973B) showed reduced inward rectification and calcium-dependent reversal potential shifts decreased by 80%, and 50%, respectively, compared with currents activated by ACh alone, indicative of reduced calcium permeability. Currents potentiated by 3a,4,5,9b-tetrahydro-4-(1-naphthalenyl)-3H-cyclopentan[c]quinoline-8-sulfonamide were also linear and showed no calcium-dependent reversal potential shifts. The ago-PAMs GAT-107 and B-973B stimulated increases in intracellular calcium in stably transfected HEK293 cells. However, these calcium signals were delayed relative to channel activation produced by these agents and were insensitive to the channel blocker mecamylamine. Our results indicate that, although allosterically activated 7 nicotinic ACh receptor may affect intracellular calcium levels, such effects are not likely due to large channel-dependent calcium influx. SIGNIFICANCE STATEMENT: Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptor can increase channel activation by two or more orders of magnitude, raising the concern that, due to the relatively high calcium permeability of α7 receptors activated by acetylcholine alone, such efficacious PAMs may have cytotoxic side effects. We show that PAMs alter the ion conduction pathway and, in general, reduce the calcium permeability of the channels. This supports the hypothesis that α7 effects on intracellular calcium may be independent of channel-mediated calcium influx.

摘要

乙酰胆碱(ACh)激活的 7 型烟碱乙酰胆碱受体的电流是短暂的。该通道对钙的通透性相对于单价阳离子较高,并表现出内向整流。先前已经注意到,在正变构调节剂(PAMs)存在下,7 型受体通道的电流在对特定通道阻断剂的敏感性及其电流-电压(I-V)关系方面与正常 7 型电流不同,不再表现出内向整流。线性 I-V 函数通常与缺乏钙通透性的通道相关,因此我们在变构结合部位结合 PAMs 后测量了 ACh 激活的 7 型受体的 I-V 功能跨膜域。在氯离子免费的林格氏溶液中记录电流,其中细胞外钙的浓度较低或较高,以确定两种条件下反转电位偏移的幅度以及 I-V 关系。由变构激动剂-PAMs(ago-PAMs)(3aR,4S,9bS)-4-(4-溴苯基)-3a,4,5,9b-四氢-3H-环戊[c]喹啉-8-磺酰胺(GAT107)和 3-(3,4-二氟苯基)-(1-(6-(4-(吡啶-2-基)哌嗪-1-基)哌嗪-2-基)乙基)丙烯酰胺(B-973B)增强的 ACh 诱发电流显示出内向整流的降低和钙依赖性反转电位偏移分别减少了 80%和 50%,与单独由 ACh 激活的电流相比,表明钙通透性降低。3a,4,5,9b-四氢-4-(1-萘基)-3H-环戊[c]喹啉-8-磺酰胺增强的电流也是线性的,没有钙依赖性反转电位偏移。ago-PAMs GAT-107 和 B-973B 刺激稳定转染的 HEK293 细胞内钙的增加。然而,这些钙信号相对于这些药物产生的通道激活延迟,并且对通道阻断剂美卡拉明不敏感。我们的结果表明,尽管变构激活的 7 型烟碱乙酰胆碱受体可能会影响细胞内钙水平,但这种作用不太可能是由于乙酰胆碱单独激活的通道依赖性钙内流引起的。

意义表述

α7 型烟碱乙酰胆碱受体的正变构调节剂(PAMs)可以使通道激活增加两个或更多数量级,这引起了人们的关注,即由于乙酰胆碱单独激活的α7 受体具有相对较高的钙通透性,这种有效的 PAMs 可能具有细胞毒性副作用。我们表明,PAMs 改变了离子传导途径,并且通常降低了通道的钙通透性。这支持了这样的假设,即α7 对细胞内钙的作用可能独立于通道介导的钙内流。